Am J Transplant, Volume 17, Suppl 3 Archives - Page 181 of 181 - ATC Abstracts

2017 American Transplant Congress
Type of Surgical Procedures and Clinical Significance of Calcineurin Inhibitor Temporary Discontinuation Regarding LT Recipients Undergoing Major Elective Surgery.
C. Cho, J. Lee, K. Kim, S. Kim, J. Lee, K. Lee, J.-M. Kim, G.-S. Choi, C. Kwon, J.-W. Joh.
Surgery, Samsung Medical Center, Seoul, Republic of Korea
Background As patients increasingly have undergone live transplantation (LT) and improved expected survival rate, there is a growing population of LT recipient undergoing elective surgery…
2017 American Transplant Congress
Retroperitoneoscopic Living Donor Nephrectomy Safely Secures Excellent Graft Function.
T. Hirose, K. Hotta, D. Iwami, H. Sasaki, H. Higuchi, Y. Takada, N. Shinohara.
Urology, Hokkaido University, Sapporo, Hokkaido, Japan
[Introduction] Laparoscopic surgery has been a standard procedure of living donor nephrectomy. Transperitoneal laparoscopic donor nephrectomy (TPLN) has been commonly reported by many centers with…
2017 American Transplant Congress
Expectations and Experiences of Follow-Up and Self-Care After Living Kidney Donation: A Focus Group Study.
K. Manera,^1,2 C. Hanson,^1,2 J. Chapman,³ J. Kanellis,^4,5 J. Gill,⁶ J. Craig,^1,2 S. Chadban,^7,8 G. Wong,^1,2,3 A. Ralph,^1,2 A. Tong.^1,2
¹Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia; ²Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia; ³Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia; ⁴Department of Nephrology, Monash Medical Centre, Clayton, VIC, Australia; ⁵Department of Medicine, Monash University, Clayton, VIC, Australia; ⁶Division of Nephrology, University of British Columbia, Vancouver, BC, Canada; ⁷Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia
Background: Ensuring donor wellbeing warrants ongoing monitoring following living kidney donation. However, there is considerable variability in donor follow up processes, including information provided to…
2017 American Transplant Congress
Adjunctive Thymoglobulin with Proteasome Inhibitor Based Treatment of Late Mixed Acute Rejection.
A. Lichvar,¹ A. Leino,¹ S. Tremblay,¹ A. Shields,² F. Paterno,¹ A. Govil,¹ M. Anand,¹ T. Diwan,¹ J. Kremer,² R. Alloway,¹ E. Woodle.¹
¹University of Cincinnati, Cincinnati; ²The Christ Hospital, Cincinnati
Proteasome inhibitor (PI) containing regimens treat mixed acute rejection (MAR) at least in part due to elimination of donor specific antibody (DSA) and via effects…
2017 American Transplant Congress
Perceived Legitimacy of Using Social Support for Transplant Eligibility: Results from a National Survey of Transplant Clinicians.
K. Ladin,¹ E. Gordon,² Z. Butt,² T. Lavelle,¹ N. Daniels,³ D. Hanto.⁴
¹Tufts University, Medford, MA; ²Northwestern University School of Medicine, Chicago; ³Harvard University, Boston; ⁴Vanderbilt University School of Medicine, Nashville
Background: Although the Centers for Medicare and Medicaid Services require that social support be used to determine transplant eligibility, guidance is vague. Centers vary significantly…
2017 American Transplant Congress
Use of Modified Geriatric Assessment in Evaluation of Older Adults for Kidney Transplant Suitability.
K. Campbell,¹ F. Enger, E. Patrick,² M. Saunders,³ M. Josephson,¹ Y. Becker.²
¹Medicine, University of Chicago, Chicago, IL; ²Kidney Transplant, University of Chicago, Chicago, IL; ³Hospital Medicine, University of Chicago, Chicago, IL
BackgroundThere is an increasing incidence and prevalence of older adults with ESRD. Per guideline recommendations, many of these patients are now being considered for kidney…